Peter Ashley Marks bought $24K of ATHE stock

Peter Ashley Marks, Dir of Alterity Therapeutics Ltd (ATHE), bought 47,620 shares of ATHE stock worth $24K, per an SEC Form 4 filed Sep 8, 2026.

It was an open-market purchase.

The trade happened on Aug 31, 2026, 8 days before it was made public.

ATHE has moved -53.3% since the trade date, from $4.49 to $2.10 (Nov 12, 2026 close).